* Apyx Medical Corp APYX.OQ reported a quarterly adjusted
loss
of 16 cents per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 19 cents per share.
* Revenue fell 8.3% to $10.29 million from a year ago;
analysts
expected $10.56 million.
* Apyx Medical Corp's reported EPS for the quarter was a
loss
of 16 cents.
* The mean earnings estimate of analysts had fallen by
about 8.2%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Apyx Medical Corp shares had risen by 84.8% this
quarter and
lost 15.5% so far this year.
* The company reported a quarterly loss of $5.43 million.
* Wall Street's median 12-month price target for Apyx
Medical Corp
is $13.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data August 11
at 09:00 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Jun. 30 2022 -0.19 -0.16 Beat
Mar. 31 2022 -0.15 -0.17 Missed
Dec. 31 2021 -0.11 -0.06 Beat
Sep. 30 2021 -0.15 -0.12 Beat